-CraZed- said:
No I don't think I am, Swedish neutrality. And no one said there wasn't any profit it is that it affects profit margins and thus the US with it's relatively open markets drug companies can charge more here to bolster those margins. Quote form SA article: :..."In Europe, meanwhile, the impact of austerity on health budgets since the financial crisis has led industry executives to complain of single-digit percentage annual price declines."Industry executives complaining that their prices, meaning what they are allowed to charge due to pricing controls, dropped by a mere single digit percentage. You don't think they are jumping at the chance to gouge US customers if they are complaining about that? |
My bad re. Sweden, didn't know that - stand corrected!
To your second point though, I understand that the European market is more challenging than the US but I'm certain there is still plenty profit to be made outside the US otherwise they wouldn't be selling to those markets. Also, even if they were making more money from Europe and others - do you really think they would treat the US any differently?
They'll maximise the profit they can make in each region, full stop. They're corporations, that's what they do...
What makes you think that a more profitable EU business would bring out their charitable side in the US?
